The pahtway p2982 has 56 genes in the original annotation. Currently, there are 36 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
|
Gene ID |
Symbol |
Synonyms |
Official Full Name |
Start Site |
End Site |
Location |
80201 | HKDC1 | - | hexokinase domain containing 1 | | | 10q22.1 |
79026 | AHNAK | AHNAKRS | AHNAK nucleoprotein | | | 11q12.2 |
4312 | MMP1 | CLG | CLGN | matrix metallopeptidase 1 | | | 11q22.3 |
7070 | THY1 | CD90 | CDw90 | Thy-1 cell surface antigen | | | 11q23.3 |
23187 | PHLDB1 | LL5A | pleckstrin homology like domain family B member 1 | | | 11q23.3 |
3678 | ITGA5 | CD49e | FNRA | VLA-5 | VLA5A | integrin subunit alpha 5 | | | 12q13.13 |
4240 | MFGE8 | BA46 | EDIL1 | HMFG | HsT19888 | MFG-E8 | MFGM | OAcGD3S | SED1 | SPAG10 | hP47 | milk fat globule-EGF factor 8 protein | | | 15q25 |
1512 | CTSH | ACC-4 | ACC-5 | ACC4 | ACC5 | CPSB | cathepsin H | | | 15q25.1 |
11057 | ABHD2 | HS1-2 | LABH2 | PHPS1-2 | abhydrolase domain containing 2 | | | 15q26.1 |
4496 | MT1H | MT-0 | MT-1H | MT-IH | MT1 | metallothionein 1H | | | 16q13 |
6347 | CCL2 | GDCF-2 | HC11 | HSMCR30 | MCAF | MCP-1 | MCP1 | SCYA2 | SMC-CF | C-C motif chemokine ligand 2 | | | 17q11.2-q12 |
3487 | IGFBP4 | BP-4 | HT29-IGFBP | IBP4 | IGFBP-4 | insulin like growth factor binding protein 4 | | | 17q21.2 |
3866 | KRT15 | CK15 | K15 | K1CO | keratin 15 | | | 17q21.2 |
3675 | ITGA3 | CD49C | FRP-2 | GAP-B3 | GAPB3 | ILNEB | MSK18 | VCA-2 | VL3A | VLA3a | integrin subunit alpha 3 | | | 17q21.33 |
6597 | SMARCA4 | BAF190 | BAF190A | BRG1 | MRD16 | RTPS2 | SNF2 | SNF2L4 | SNF2LB | SWI2 | hSNF2b | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | | | 19p13.2 |
81 | ACTN4 | ACTININ-4 | FSGS | FSGS1 | actinin alpha 4 | | | 19q13 |
100124696 | TEC | - | transient erythroblastopenia of childhood | | | 19q13.2 |
1647 | GADD45A | DDIT1 | GADD45 | growth arrest and DNA damage inducible alpha | | | 1p31.2 |
2048 | EPHB2 | CAPB | DRT | EK5 | EPHT3 | ERK | Hek5 | PCBC | Tyro5 | EPH receptor B2 | | | 1p36.1-p35 |
6273 | S100A2 | CAN19 | S100L | S100 calcium binding protein A2 | | | 1q21 |
4000 | LMNA | CDCD1 | CDDC | CMD1A | CMT2B1 | EMD2 | FPL | FPLD | FPLD2 | HGPS | IDC | LDP1 | LFP | LGMD1B | LMN1 | LMNC | LMNL1 | PRO1 | lamin A/C | | | 1q22 |
5778 | PTPN7 | BPTP-4 | HEPTP | LC-PTP | LPTP | PTPNI | protein tyrosine phosphatase, non-receptor type 7 | | | 1q32.1 |
493 | ATP2B4 | ATP2B2 | MXRA1 | PMCA4 | PMCA4b | PMCA4x | ATPase plasma membrane Ca2+ transporting 4 | | | 1q32.1 |
183 | AGT | ANHU | SERPINA8 | angiotensinogen | | | 1q42.2 |
23654 | PLXNB2 | MM1 | Nbla00445 | PLEXB2 | dJ402G11.3 | plexin B2 | | | 22q13.33 |
2355 | FOSL2 | FRA2 | FOS like antigen 2 | | | 2p23.3 |
5270 | SERPINE2 | GDN | GDNPF | PI-7 | PI7 | PN-1 | PN1 | PNI | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | | | 2q36.1 |
2317 | FLNB | ABP-278 | ABP-280 | AOI | FH1 | FLN-B | FLN1L | LRS1 | SCT | TABP | TAP | filamin B | | | 3p14.3 |
131566 | DCBLD2 | CLCP1 | ESDN | discoidin, CUB and LCCL domain containing 2 | | | 3q12.1|3 |
7006 | TEC | PSCTK4 | tec protein tyrosine kinase | | | 4p12 |
4131 | MAP1B | FUTSCH | MAP5 | PPP1R102 | microtubule associated protein 1B | | | 5q13 |
1026 | CDKN1A | CAP20 | CDKN1 | CIP1 | MDA-6 | P21 | SDI1 | WAF1 | p21CIP1 | cyclin-dependent kinase inhibitor 1A | | | 6p21.2 |
7328 | UBE2H | E2-20K | GID3 | UBC8 | UBCH | UBCH2 | ubiquitin conjugating enzyme E2 H | | | 7q32 |
1508 | CTSB | APPS | CPSB | cathepsin B | | | 8p22 |
54704 | PDP1 | PDH | PDP | PDPC | PPM2A | PPM2C | pyruvate dehyrogenase phosphatase catalytic subunit 1 | | | 8q22.1 |
6595 | SMARCA2 | BAF190 | BRM | NCBRS | SNF2 | SNF2L2 | SNF2LA | SWI2 | Sth1p | hBRM | hSNF2a | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | | | 9p22.3 |